Pancreatic Cancer Canada and IMD Health Global announce partnership to improve the quality of patient education
Toronto – July 21, 2022
Pancreatic Cancer Canada is pleased to announce an important new partnership with IMD Health. IMD Health is the largest digital health educational platform in Canada. IMD offers innovative technology that facilitates meaningful dialogue between healthcare professionals and patients inside the examination room, hospital bedsides, pharmacy consultations and during virtual consultations. IMD’s award-winning platform enables healthcare professionals to instantly access over 110,000 media-rich educational graphics, videos and resources during consults as well as by patients at home.
“When it comes to a fast-moving disease like pancreatic cancer, patients and caregivers need disease-related resources to better understand their diagnosis and make informed treatment decisions at every stage of their journey. As the leading authority on pancreatic cancer in Canada, we are thrilled to partner with IMD Health to increase access to information for patients and healthcare providers,” said Jonathan Paul, Board Chair, Pancreatic Cancer Canada.
IMD curates medical diagrams, patient brochures, and educational videos from over 100 non-profit health organizations and pharmaceutical manufacturers and puts them at the fingertips of healthcare professionals via an easy-to-use tool. Content is securely emailed to patients for later review, increasing patient understanding of their condition and treatment plan, ultimately improving their health outcomes. In addition, they host thousands of healthcare professional-facing resources, including information about medications, clinical practice guidelines, and providing culturally competent care.
“We are very excited to collaborate with Pancreatic Cancer Canada to provide our clinicians, patients and their families with trusted information to provide support to individuals with pancreatic cancer in Canada” said Alice Haidau, Medical Content Manager, IMD, citing the need for inclusive, evidence-based health information, particularly given the shift toward digital tools incited by the pandemic, and internet use which often leads to misinformation.
Pancreatic Cancer Canada’s resources are now available on IMD. IMD’s established healthcare provider network can send patients home with resource packages on risk factors, treatment options, diet and nutrition guides, clinical trials, and more.
Patients can self-educate and become active participants in their care with IMD’s patient site. Access medically vetted, reliable, and engaging resources from 100+ health associations, including Pancreatic Cancer Canada, Wellspring, and more.
About Pancreatic Cancer Canada
Pancreatic Cancer Canada is fighting to raise survival rates for the world’s toughest cancer by investing in targeted research, increased awareness and patient support, community activation and advocacy. We have taken on one of the world’s deadliest cancers — a disease with virtually no progress in survival in the past 40 years and a 90% mortality rate. We are aggressively fighting it with investments in research aimed at greater understanding of this cancer and better treatment options. At the same time, we are working to educate physicians about faster diagnosis and with patients/families to support them as they face the realities of this cancer at every stage.
Learn more at https://pancreaticcancercanada.ca/.
For more information, contact Victoria Izzio-Meloche, Digital Communications Specialist, at vizzio-meloche@pccf.ca.
About IMD Health Global
IMD Health Global is a Toronto-based eHealth software development company, focused on innovating healthcare education. Since 2010, IMD has grown into Canada’s largest digital patient engagement platform. Centred “At The Point of Care” ®, healthcare professionals use IMD’s cloud-based platform (in clinic or virtual consults) to engage with their patients at a deeper level and optimize knowledge transfer surrounding a patient’s condition and treatment plan. This is done through the seamless integration of over 110,000 images, booklets, and video resources, (covering 5,600 health topics) into an award-winning user interface that makes patient education both efficient and effective. At the end of a patient’s consult, a summary of all the discussed information can be emailed to the patient to review and continue their learning journey at home, improving their health literacy and adherence to their treatment plan. The IMD platform is utilized by over 14,300 practitioners (doctors, nurses and pharmacists in, clinics, hospitals, pharmacies, infusion clinics and in homecare settings. For more information please visit: www.IMDhealth.com and https://app.IMDhealth.com IMD Health is a subsidiary of CloudMD Software & Services (TSXV: DOC)
For more information, contact Jared Sonnenberg, VP, at jared.sonnenberg@IMDhealth.com.
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes the leading Student Assistance Program and one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America. For more information visit: https://investors.cloudmd.ca